查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726250

监管应用市场规模、份额、趋势分析报告（按服务、类别、产品类型、公司规模、产品阶段、适应症、最终用途、地区和细分趋势）：2025 年至 2030 年

Regulatory Affairs Market Size, Share & Trends Analysis Report By Services (Regulatory Consulting, Legal Representation), By Categories, By Type, By Company Size, By Product Stage, By Indication, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

监管应用市场的成长和趋势

根据Grand View Research, Inc.的最新报告，全球监管应用市场规模预计到2030年将达到271.8亿美元，2025年至2030年期间的复合年增长率为8.80%。

预计有助于市场成长的因素包括跨业务活动和地区的监管要求的变化、由于监管核准速度加快而导致的临床测试和药物核准的增加，以及监管软体的技术进步。促进市场成长的其他因素包括个人化医疗的发展、公司越来越需要专注于其核心业务活动以及经济和竞争压力。

製药公司和监管机构联手快速开发对抗 COVID-19 感染所需的疫苗和医疗产品。监管机构已采取多项预防措施，以确保临床试验期间患者和人员的安全，并确保维护资料完整性和良好的实验室业务。生物相似药、孤儿药、个人化药物、伴随诊断和自适应测试设计市场的成长预计将推动这些领域对监管专业知识的需求。随着公司向新的领域扩张，遵守法规的需求也随之增加，对拥有监管业务专业知识的专业服务供应商的需求也日益增长。由于Simulect、 Vectibix、 Mircera、Kineret等生技药品的专利到期，生物相似药的需求和发展日益增加，从而推动了对监管服务的需求。

为了在个人化医疗市场占据主导，一些公司正在积极建立联盟并开发新产品，这表明需要监管业务支援。例如，2020 年 5 月，再生元製药公司 (Regeneron Pharmaceuticals, Inc.) 与科罗拉多州个人化医疗中心合作，推动个人化医疗和人类遗传学领域的进步。

监理应用市场报告重点

  • 2024年，外包领域占据市场主导地位，占有59.05%的份额。该领域的成长主要是由于製药和医疗设备公司转向外包以获取其内部所不具备的专业知识和资源。
  • 预计监管写作和出版领域将在 2024 年占据主要市场份额。该领域的成长归因于一些製药和生物製药公司正在削减成本、优先考虑战略计划、减少员工培训时间、提高整体效率并提供更大的灵活性。
  • 2024 年的监管应用市场将以製药领域为主。此部分的成长归因于流程中每个阶段涉及的各种法规和相关监管备案/文件。
  • 2024 年，肿瘤学领域将占据市场主导地位。该领域的成长是由于癌症盛行率的不断上升，需要有效且安全的治疗方案。
  • 2024 年，临床研究将占据市场主导地位。慢性病盛行率的不断上升以及新疾病的出现将推动对更好治疗方案的需求，从而进一步增加全球进行的临床试验数量，以满足患者日益增长的需求。
  • 2024 年的市场规模主要由中型企业市场主导。该市场的成长主要归功于中型公司（主要是非上市公司）的大量存在。
  • 2024年的市场规模将以製药公司为主。该领域的成长归因于研发活动的增加以及核准药物数量的增加。
  • 亚太地区监管应用市场占据全球市场主导地位，2024 年占有 38.03% 的份额。

目录

第一章调查方法与范围

第二章执行摘要

第 3 章监理应用市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章：医药事务市场：按服务进行的估计和趋势分析

  • 细分仪表板
  • 全球监管应用市场服务变化分析
  • 全球监理应用市场规模及趋势分析（按服务，2018-2030年）
  • 监理咨询
  • 法律代表
  • 监管文件的撰写和发布
  • 产品註册和临床试验申请
  • 其他的

第五章：药物应用市场：按类别的估计和趋势分析

  • 细分仪表板
  • 全球监理应用市场类别变化分析
  • 全球监理应用市场规模及趋势分析（分类别，2018-2030年）
  • 药物
    • 创新者
    • 学名药
  • 生技药品
    • 生物技术
    • ATMP
  • 生物相似药
  • 医疗设备
    • 诊断
    • 治疗

第六章 医药市场：依适应症的估计与趋势分析

  • 细分仪表板
  • 全球医药应用市场适应症变化分析
  • 全球监理应用市场规模及趋势分析（按适应症，2018-2030年）
  • 肿瘤学
  • 神经病学
  • 心臟病学
  • 免疫学
  • 其他的

第七章：监理应用市场：依产品阶段的估计与趋势分析

  • 细分仪表板
  • 全球监理申请市场产品阶段变化分析
  • 全球监理应用市场规模及趋势分析（依产品阶段，2018-2030年）
  • 临床前
  • 临床研究
  • 上市前核准（PMA）

第 8 章：药物应用市场类型、估计与趋势分析

  • 细分仪表板
  • 全球监管应用市场类型变化分析
  • 全球监理备案市场规模及趋势分析（2018-2030 年）
  • 内部
  • 外包

第九章：医药事务市场：依公司规模的估计与趋势分析

  • 细分仪表板
  • 全球医药应用市场公司规模变化分析
  • 全球监理应用市场规模及趋势分析（依公司规模，2018-2030年）
  • 小的
  • 中等的
  • 大的

第 10 章：监管应用市场 - 按最终用途的估计和趋势分析

  • 细分仪表板
  • 全球监管应用市场最终用途变化分析
  • 全球监理应用市场规模及趋势分析（依最终用途，2018-2030年）
  • 医疗设备公司
  • 製药公司
  • 生技公司

第 11 章：监管应用市场：按地区分類的估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 挪威
    • 荷兰
    • 瑞士
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
    • 印尼
    • 马来西亚
    • 新加坡
    • 台湾
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
    • 智利
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 埃及
    • 以色列
    • 科威特

第十二章竞争格局

  • 竞争性分类
    • 市场领导者
    • 新参与企业
  • 2024 年公司市场占有率/估值分析
  • 公司简介
    • Accell Clinical Research, LLC
    • Genpact
    • Criterium, Inc.
    • ICON plc
    • iuvo BioScience, LLC.
    • WuXi AppTec
    • Medpace
    • Charles River Laboratories
    • Laboratory Corporation of America Holdings
    • Parexel International（MA）Corporation
    • Freyr
    • PHARMALEX GMBH
    • SSI Strategy LLC
    • Pharmexon
    • Qvigilance
    • BlueReg
    • Cambridge Regulatory Services
    • VCLS
Product Code: GVR-4-68039-065-9

Regulatory Affairs Market Growth & Trends:

The global regulatory affairs market size is expected to reach USD 27.18 billion by 2030, expanding at a CAGR of 8.80% from 2025 to 2030, according to a new report by Grand View Research, Inc. The factors expected to contribute to the growth of this market include changing regulatory requirements based on business activities and geographies, an increase in clinical trials & drug approvals along with accelerated regulatory approval, and technological advancement in regulatory software. Also, the evolution of personalized medicines, the increasing need for companies to focus on core business activities, and economic and competitive pressures are other factors that are contributing to the growth of the market.

The pharmaceutical and regulatory agencies joined forces to rapidly develop vaccines and medical products required to fight against the COVID-19 infection. The regulatory authorities take numerous precautions to ensure patient and personnel safety during a clinical trial, as well as data integrity and good laboratory practices are maintained. Growth in markets for biosimilars, orphan drugs, personalized medicines, companion diagnostics, and adaptive trial designs is projected to boost the demand for regulatory specialization in these areas. As companies venture into newer fields, the growing need to comply with regulations is boosting the demand for specialized service providers with expertise in regulatory affairs. Patent expiration of biologics, such as Simulect, Vectibix, Mircera, and Kineret, is increasing the demand and development of biosimilars, thereby contributing to the demand for regulatory services.

Several companies are actively involved in collaborations and new product development to gain leadership in the personalized medicine market, indicating a need for supportive regulatory affairs. For instance, in May 2020, Regeneron Pharmaceuticals, Inc. collaborated with Colorado Center for Personalized Medicine to design advancements in personalized medicine and human genetics.

Regulatory Affairs Market Report Highlights:

  • The outsourcing segment dominated the market with a share of 59.05% in 2024. The growth of the segment is mainly due to the growing focus of the pharmaceutical and medical device companies to outsource their activities as it allows access to specialized expertise and resources that they may not have in-house.
  • The regulatory writing & publishing segment held a significant share of the market in 2024. The growth of the segment is attributed to several pharmaceutical or biopharmaceutical companies reducing costs, prioritizing strategic projects, reducing staff training time, and improving overall efficiency, as well as providing greater flexibility.
  • The drugs segment dominated the regulatory affairs market in 2024. The growth of the segment can be attributed to various regulations and related regulatory submissions/documentation at each of the steps involved in the process.
  • The oncology segment dominated the market in 2024. The growth of the segment is due to the increasing prevalence of cancer, which requires effective and safe treatment options.
  • Clinical studies dominated the market in 2024. The increasing prevalence of chronic diseases coupled with the emergence of new diseases will increase the demand for better treatment options, further growing the number of clinical trials conducted globally to meet the growing needs of the patients.
  • The medium company size segment dominated the market in 2024. The growth of the market is mainly due to the strong presence of several mid-sized established firms, mainly which are privately held.
  • The pharmaceutical companies segment dominated the market in 2024. The growth of the segment is due to growing research and development activities coupled with an increase in the number of approved pharmaceutical products.
  • The regulatory affairs market in Asia Pacific dominated the global industry and accounted for a 38.03% share in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Information Analysis
    • 1.4.2. Market Formulation & Data Visualization
    • 1.4.3. Data Validation & Publishing
  • 1.5. Model Details
    • 1.5.1. Commodity Flow Analysis (Model 1)
    • 1.5.2. Top Down Market Estimation (Model 2)
    • 1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
    • 1.5.4. Multivariate Analysis (Model 4)
  • 1.6. List of Secondary Sources
  • 1.7. List of Abbreviations
  • 1.8. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Regulatory Affairs Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Changing regulatory landscape
      • 3.2.1.2. Entry of companies into the global market
      • 3.2.1.3. Life science companies focusing on their core competencies
      • 3.2.1.4. Economic and competitive pressures
      • 3.2.1.5. Demand for the faster approval process for breakthrough drugs and devices
      • 3.2.1.6. Growth in emerging areas such as personalized medicine, biosimilars, and orphan drugs
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Risk Associated with Data Security
      • 3.2.2.2. Monitoring Issues and Lack of Standardization
  • 3.3. Industry Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Regulatory Affairs Market: Services Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Regulatory Affairs Market Services Movement Analysis
  • 4.3. Global Regulatory Affairs Market Size & Trend Analysis, by Services, 2018 to 2030 (USD Million)
  • 4.4. Regulatory Consulting
    • 4.4.1. Regulatory consulting market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Legal Representation
    • 4.5.1. Legal representation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Regulatory Writing & Publishing
    • 4.6.1. Regulatory writing & publishing market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.6.1.1. Writing
        • 4.6.1.1.1. Writing market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.6.1.2. Publishing
        • 4.6.1.2.1. Publishing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7. Product Registration & Clinical Trial Applications
    • 4.7.1. Product registration & clinical trial applications market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.8. Other Services
    • 4.8.1. Other services market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Regulatory Affairs Market: Category Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Regulatory Affairs Market Category Movement Analysis
  • 5.3. Global Regulatory Affairs Market Size & Trend Analysis, by Category, 2018 to 2030 (USD Million)
  • 5.4. Drugs
    • 5.4.1. Drugs market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Innovator
      • 5.4.2.1. Innovator market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.4.2.2. Preclinical
        • 5.4.2.2.1. Preclinical market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.4.2.3. Clinical
        • 5.4.2.3.1. Clinical market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.4.2.4. Pre-Market Approval (PMA)
        • 5.4.2.4.1. Pre-Market Approval (PMA) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Generics
      • 5.4.3.1. Generics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.4.3.2. Preclinical
        • 5.4.3.2.1. Preclinical market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.4.3.3. Clinical
        • 5.4.3.3.1. Clinical market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.4.3.4. Pre-Market Approval (PMA)
        • 5.4.3.4.1. Pre-Market Approval (PMA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Biologics
    • 5.5.1. Biologics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Biotech
      • 5.5.2.1. Biotech market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.5.2.2. Preclinical
        • 5.5.2.2.1. Preclinical market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.5.2.3. Clinical
        • 5.5.2.3.1. Clinical market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.5.2.4. Pre-Market Approval (PMA)
        • 5.5.2.4.1. Pre-Market Approval (PMA) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. ATMP
      • 5.5.3.1. ATMP market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.5.3.2. Preclinical
        • 5.5.3.2.1. Preclinical market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.5.3.3. Clinical
        • 5.5.3.3.1. Clinical market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.5.3.4. Pre-Market Approval (PMA)
        • 5.5.3.4.1. Pre-Market Approval (PMA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Biosimilars
    • 5.6.1. Biosimilars market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.6.1.1. Preclinical
        • 5.6.1.1.1. Preclinical market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.6.1.2. Clinical
        • 5.6.1.2.1. Clinical market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.6.1.3. Pre-Market Approval (PMA)
        • 5.6.1.3.1. Pre-Market Approval (PMA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. Medical Devices
    • 5.7.1. Medical devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.2. Diagnostics
      • 5.7.2.1. Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.7.2.2. Preclinical
        • 5.7.2.2.1. Preclinical market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.7.2.3. Clinical
        • 5.7.2.3.1. Clinical market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.7.2.4. Pre-Market Approval (PMA)
        • 5.7.2.4.1. Pre-Market Approval (PMA) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Therapeutics
      • 5.7.3.1. Therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.7.3.2. Preclinical
        • 5.7.3.2.1. Preclinical market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.7.3.3. Clinical
        • 5.7.3.3.1. Clinical market estimates and forecasts, 2018 - 2030 (USD Million)
      • 5.7.3.4. Pre-Market Approval (PMA)
        • 5.7.3.4.1. Pre-Market Approval (PMA) market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Regulatory Affairs Market: Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Regulatory Affairs Market Indication Movement Analysis
  • 6.3. Global Regulatory Affairs Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Neurology
    • 6.5.1. Neurology market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Cardiology
    • 6.6.1. Cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Immunology
    • 6.7.1. Immunology market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8. Others
    • 6.8.1.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Regulatory Affairs Market: Product Stage Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Regulatory Affairs Market Product Stage Movement Analysis
  • 7.3. Global Regulatory Affairs Market Size & Trend Analysis, by Product Stage, 2018 to 2030 (USD Million)
  • 7.4. Preclinical
    • 7.4.1. Preclinical market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Clinical studies
    • 7.5.1. Clinical studies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Pre-Market Approval (PMA)
    • 7.6.1. Pre-Market Approval (PMA) market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Regulatory Affairs Market: Type Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Regulatory Affairs Market Type Movement Analysis
  • 8.3. Global Regulatory Affairs Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 8.4. In-house
    • 8.4.1. In-house market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5. Outsourced
    • 8.5.1. Outsourced market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Regulatory Affairs Market: Company Size Estimates & Trend Analysis

  • 9.1. Segment Dashboard
  • 9.2. Global Regulatory Affairs Market Company Size Movement Analysis
  • 9.3. Global Regulatory Affairs Market Size & Trend Analysis, by Company Size, 2018 to 2030 (USD Million)
  • 9.4. Small
    • 9.4.1. Small market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.5. Medium
    • 9.5.1. Medium market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.6. Large
    • 9.6.1. Large market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 10. Regulatory Affairs Market: End-use Estimates & Trend Analysis

  • 10.1. Segment Dashboard
  • 10.2. Global Regulatory Affairs Market End-use Movement Analysis
  • 10.3. Global Regulatory Affairs Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 10.4. Medical Device Companies
    • 10.4.1. Medical device companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.5. Pharmaceutical Companies
    • 10.5.1. Pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.6. Biotechnology Companies
    • 10.6.1. Biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 11. Regulatory Affairs Market: Regional Estimates & Trend Analysis

  • 11.1. Regional Market Share Analysis, 2024 & 2030
  • 11.2. Regional Market Dashboard
  • 11.3. Market Size & Forecasts Trend Analysis, 2018 to 2030 (USD Million)
  • 11.4. North America
    • 11.4.1. North America Market Estimates and Forecasts 2018 to 2030, (USD Million)
    • 11.4.2. U.S.
      • 11.4.2.1. Key country dynamics
      • 11.4.2.2. Competitive scenario
      • 11.4.2.3. Regulatory scenario
      • 11.4.2.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.4.3. Canada
      • 11.4.3.1. Key country dynamics
      • 11.4.3.2. Competitive scenario
      • 11.4.3.3. Regulatory scenario
      • 11.4.3.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.4.4. Mexico
      • 11.4.4.1. Key country dynamics
      • 11.4.4.2. Competitive scenario
      • 11.4.4.3. Regulatory scenario
      • 11.4.4.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • 11.5. Europe
    • 11.5.1. Europe Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 11.5.2. UK
      • 11.5.2.1. Key country dynamics
      • 11.5.2.2. Competitive scenario
      • 11.5.2.3. Regulatory scenario
      • 11.5.2.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.5.3. Germany
      • 11.5.3.1. Key country dynamics
      • 11.5.3.2. Competitive scenario
      • 11.5.3.3. Regulatory scenario
      • 11.5.3.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.5.4. France
      • 11.5.4.1. Key country dynamics
      • 11.5.4.2. Competitive scenario
      • 11.5.4.3. Regulatory scenario
      • 11.5.4.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.5.5. Italy
      • 11.5.5.1. Key country dynamics
      • 11.5.5.2. Competitive scenario
      • 11.5.5.3. Regulatory scenario
      • 11.5.5.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.5.6. Spain
      • 11.5.6.1. Key country dynamics
      • 11.5.6.2. Competitive scenario
      • 11.5.6.3. Regulatory scenario
      • 11.5.6.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.5.7. Denmark
      • 11.5.7.1. Key country dynamics
      • 11.5.7.2. Competitive scenario
      • 11.5.7.3. Regulatory scenario
      • 11.5.7.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.5.8. Norway
      • 11.5.8.1. Key country dynamics
      • 11.5.8.2. Competitive scenario
      • 11.5.8.3. Regulatory scenario
      • 11.5.8.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.5.9. Netherlands
      • 11.5.9.1. Key country dynamics
      • 11.5.9.2. Competitive scenario
      • 11.5.9.3. Regulatory scenario
      • 11.5.9.4. Netherlands market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.5.10. Switzerland
      • 11.5.10.1. Key country dynamics
      • 11.5.10.2. Competitive scenario
      • 11.5.10.3. Regulatory scenario
      • 11.5.10.4. Switzerland market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.5.11. Sweden
      • 11.5.11.1. Key country dynamics
      • 11.5.11.2. Competitive scenario
      • 11.5.11.3. Regulatory scenario
      • 11.5.11.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • 11.6. Asia Pacific
    • 11.6.1. Asia Pacific Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 11.6.2. Japan
      • 11.6.2.1. Key country dynamics
      • 11.6.2.2. Competitive scenario
      • 11.6.2.3. Regulatory scenario
      • 11.6.2.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.6.3. China
      • 11.6.3.1. Key country dynamics
      • 11.6.3.2. Competitive scenario
      • 11.6.3.3. Regulatory scenario
      • 11.6.3.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.6.4. India
      • 11.6.4.1. Key country dynamics
      • 11.6.4.2. Competitive scenario
      • 11.6.4.3. Regulatory scenario
      • 11.6.4.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.6.5. Australia
      • 11.6.5.1. Key country dynamics
      • 11.6.5.2. Competitive scenario
      • 11.6.5.3. Regulatory scenario
      • 11.6.5.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.6.6. South Korea
      • 11.6.6.1. Key country dynamics
      • 11.6.6.2. Competitive scenario
      • 11.6.6.3. Regulatory scenario
      • 11.6.6.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.6.7. Thailand
      • 11.6.7.1. Key country dynamics
      • 11.6.7.2. Competitive scenario
      • 11.6.7.3. Regulatory scenario
      • 11.6.7.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.6.8. Indonesia
      • 11.6.8.1. Key country dynamics
      • 11.6.8.2. Competitive scenario
      • 11.6.8.3. Regulatory scenario
      • 11.6.8.4. Indonesia market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.6.9. Malaysia
      • 11.6.9.1. Key country dynamics
      • 11.6.9.2. Competitive scenario
      • 11.6.9.3. Regulatory scenario
      • 11.6.9.4. Malaysia market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.6.10. Singapore
      • 11.6.10.1. Key country dynamics
      • 11.6.10.2. Competitive scenario
      • 11.6.10.3. Regulatory scenario
      • 11.6.10.4. Singapore market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.6.11. Taiwan
      • 11.6.11.1. Key country dynamics
      • 11.6.11.2. Competitive scenario
      • 11.6.11.3. Regulatory scenario
      • 11.6.11.4. Taiwan market estimates and forecasts, 2018 - 2030 (USD Million)
  • 11.7. Latin America
    • 11.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 11.7.2. Brazil
      • 11.7.2.1. Key country dynamics
      • 11.7.2.2. Competitive scenario
      • 11.7.2.3. Regulatory scenario
      • 11.7.2.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.7.3. Argentina
      • 11.7.3.1. Key country dynamics
      • 11.7.3.2. Competitive scenario
      • 11.7.3.3. Regulatory scenario
      • 11.7.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.7.4. Colombia
      • 11.7.4.1. Key country dynamics
      • 11.7.4.2. Competitive scenario
      • 11.7.4.3. Regulatory scenario
      • 11.7.4.4. Colombia market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.7.5. Chile
      • 11.7.5.1. Key country dynamics
      • 11.7.5.2. Competitive scenario
      • 11.7.5.3. Regulatory scenario
      • 11.7.5.4. Chile market estimates and forecasts, 2018 - 2030 (USD Million)
  • 11.8. MEA
    • 11.8.1. MEA Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 11.8.2. South Africa
      • 11.8.2.1. Key country dynamics
      • 11.8.2.2. Competitive scenario
      • 11.8.2.3. Regulatory scenario
      • 11.8.2.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.8.3. Saudi Arabia
      • 11.8.3.1. Key country dynamics
      • 11.8.3.2. Competitive scenario
      • 11.8.3.3. Regulatory scenario
      • 11.8.3.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.8.4. UAE
      • 11.8.4.1. Key country dynamics
      • 11.8.4.2. Competitive scenario
      • 11.8.4.3. Regulatory scenario
      • 11.8.4.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.8.5. Egypt
      • 11.8.5.1. Key country dynamics
      • 11.8.5.2. Competitive scenario
      • 11.8.5.3. Regulatory scenario
      • 11.8.5.4. Egypt market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.8.6. Israel
      • 11.8.6.1. Key country dynamics
      • 11.8.6.2. Competitive scenario
      • 11.8.6.3. Regulatory scenario
      • 11.8.6.4. Israel market estimates and forecasts, 2018 - 2030 (USD Million)
    • 11.8.7. Kuwait
      • 11.8.7.1. Key country dynamics
      • 11.8.7.2. Competitive scenario
      • 11.8.7.3. Regulatory scenario
      • 11.8.7.4. Israel market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 12. Competitive Landscape

  • 12.1. Competition Categorization
    • 12.1.1. Market Leaders
    • 12.1.2. Emerging Players
  • 12.2. Company Market Share/Assessment Analysis, 2024
  • 12.3. Company Profiles
    • 12.3.1. Accell Clinical Research, LLC
      • 12.3.1.1. Company overview
      • 12.3.1.2. Financial performance
      • 12.3.1.3. Service benchmarking
      • 12.3.1.4. Strategic initiatives
    • 12.3.2. Genpact
      • 12.3.2.1. Company overview
      • 12.3.2.2. Financial performance
      • 12.3.2.3. Service benchmarking
      • 12.3.2.4. Strategic initiatives
    • 12.3.3. Criterium, Inc.
      • 12.3.3.1. Company overview
      • 12.3.3.2. Financial performance
      • 12.3.3.3. Service benchmarking
      • 12.3.3.4. Strategic initiatives
    • 12.3.4. ICON plc
      • 12.3.4.1. Company overview
      • 12.3.4.2. Financial performance
      • 12.3.4.3. Service benchmarking
      • 12.3.4.4. Strategic initiatives
    • 12.3.5. iuvo BioScience, LLC.
      • 12.3.5.1. Company overview
      • 12.3.5.2. Financial performance
      • 12.3.5.3. Service benchmarking
      • 12.3.5.4. Strategic initiatives
    • 12.3.6. WuXi AppTec
      • 12.3.6.1. Company overview
      • 12.3.6.2. Financial performance
      • 12.3.6.3. Service benchmarking
      • 12.3.6.4. Strategic initiatives
    • 12.3.7. Medpace
      • 12.3.7.1. Company overview
      • 12.3.7.2. Financial performance
      • 12.3.7.3. Service benchmarking
      • 12.3.7.4. Strategic initiatives
    • 12.3.8. Charles River Laboratories
      • 12.3.8.1. Company overview
      • 12.3.8.2. Financial performance
      • 12.3.8.3. Service benchmarking
      • 12.3.8.4. Strategic initiatives
    • 12.3.9. Laboratory Corporation of America Holdings
      • 12.3.9.1. Company overview
      • 12.3.9.2. Financial performance
      • 12.3.9.3. Service benchmarking
      • 12.3.9.4. Strategic initiatives
    • 12.3.10. Parexel International (MA) Corporation
      • 12.3.10.1. Company overview
      • 12.3.10.2. Financial performance
      • 12.3.10.3. Service benchmarking
      • 12.3.10.4. Strategic initiatives
    • 12.3.11. Freyr
      • 12.3.11.1. Company overview
      • 12.3.11.2. Financial performance
      • 12.3.11.3. Service benchmarking
      • 12.3.11.4. Strategic initiatives
    • 12.3.12. PHARMALEX GMBH
      • 12.3.12.1. Company overview
      • 12.3.12.2. Financial performance
      • 12.3.12.3. Service benchmarking
      • 12.3.12.4. Strategic initiatives
    • 12.3.13. SSI Strategy LLC
      • 12.3.13.1. Company overview
      • 12.3.13.2. Financial performance
      • 12.3.13.3. Service benchmarking
      • 12.3.13.4. Strategic initiatives
    • 12.3.14. Pharmexon
      • 12.3.14.1. Company overview
      • 12.3.14.2. Financial performance
      • 12.3.14.3. Service benchmarking
      • 12.3.14.4. Strategic initiatives
    • 12.3.15. Qvigilance
      • 12.3.15.1. Company overview
      • 12.3.15.2. Financial performance
      • 12.3.15.3. Service benchmarking
      • 12.3.15.4. Strategic initiatives
    • 12.3.16. BlueReg
      • 12.3.16.1. Company overview
      • 12.3.16.2. Financial performance
      • 12.3.16.3. Service benchmarking
      • 12.3.16.4. Strategic initiatives
    • 12.3.17. Cambridge Regulatory Services
      • 12.3.17.1. Company overview
      • 12.3.17.2. Financial performance
      • 12.3.17.3. Service benchmarking
      • 12.3.17.4. Strategic initiatives
    • 12.3.18. VCLS
      • 12.3.18.1. Company overview
      • 12.3.18.2. Financial performance
      • 12.3.18.3. Service benchmarking
      • 12.3.18.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 4 Global Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 5 Global Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 6 Global Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 7 Global Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 8 Global Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 9 Global Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 10 Global Regulatory Affairs Market, by Region, 2018 - 2030 (USD Million)
  • Table 11 North America Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 12 North America Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 13 North America Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 14 North America Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 15 North America Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 16 North America Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 17 North America Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 18 U.S. Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 19 U.S. Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 20 U.S. Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 21 U.S. Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 22 U.S. Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 23 U.S. Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 24 U.S. Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 25 Canada Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 26 Canada Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 27 Canada Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 28 Canada Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 29 Canada Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 30 Canada Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 31 Canada Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 32 Mexico Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 33 Mexico Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 34 Mexico Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 35 Mexico Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 36 Mexico Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 37 Mexico Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 38 Mexico Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 39 Europe Regulatory Affairs Market, by Country, 2018 - 2030 (USD Million)
  • Table 40 Europe Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 41 Europe Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 42 Europe Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 43 Europe Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 44 Europe Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 45 Europe Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 46 Europe Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 47 Germany Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 48 Germany Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 49 Germany Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 50 Germany Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 51 Germany Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 52 Germany Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 53 Germany Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 54 UK Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 55 UK Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 56 UK Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 57 UK Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 58 UK Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 59 UK Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 60 UK Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 61 France Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 62 France Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 63 France Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 64 France Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 65 France Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 66 France Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 67 France Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 68 Italy Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 69 Italy Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 70 Italy Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 71 Italy Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 72 Italy Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 73 Italy Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 74 Italy Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 75 Spain Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 76 Spain Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 77 Spain Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 78 Spain Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 79 Spain Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 80 Spain Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 81 Spain Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 82 Denmark Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 83 Denmark Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 84 Denmark Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 85 Denmark Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 86 Denmark Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 87 Denmark Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 88 Denmark Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 89 Norway Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 90 Norway Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 91 Norway Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 92 Norway Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 93 Norway Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 94 Norway Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 95 Norway Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 96 Netherlands Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 97 Netherlands Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 98 Netherlands Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 99 Netherlands Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 100 Netherlands Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 101 Netherlands Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 102 Netherlands Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 103 Switzerland Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 104 Switzerland Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 105 Switzerland Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 106 Switzerland Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 107 Switzerland Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 108 Switzerland Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 109 Switzerland Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 110 Sweden Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 111 Sweden Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 112 Sweden Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 113 Sweden Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 114 Sweden Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 115 Sweden Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 116 Sweden Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 117 Asia Pacific Regulatory Affairs Market, by Country, 2018 - 2030 (USD Million)
  • Table 118 Asia Pacific Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 119 Asia Pacific Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 120 Asia Pacific Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 121 Asia Pacific Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 122 Asia Pacific Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 123 Asia Pacific Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 124 Asia Pacific Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 125 China Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 126 China Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 127 China Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 128 China Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 129 China Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 130 China Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 131 China Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 132 Japan Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 133 Japan Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 134 Japan Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 135 Japan Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 136 Japan Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 137 Japan Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 138 Japan Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 139 India Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 140 India Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 141 India Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 142 India Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 143 India Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 144 India Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 145 India Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 146 South Korea Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 147 South Korea Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 148 South Korea Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 149 South Korea Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 150 South Korea Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 151 South Korea Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 152 South Korea Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 153 Australia Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 154 Australia Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 155 Australia Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 156 Australia Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 157 Australia Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 158 Australia Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 159 Australia Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 160 Thailand Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 161 Thailand Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 162 Thailand Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 163 Thailand Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 164 Thailand Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 165 Thailand Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 166 Thailand Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 167 Indonesia Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 168 Indonesia Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 169 Indonesia Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 170 Indonesia Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 171 Indonesia Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 172 Indonesia Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 173 Indonesia Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 174 Malaysia Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 175 Malaysia Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 176 Malaysia Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 177 Malaysia Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 178 Malaysia Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 179 Malaysia Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 180 Malaysia Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 181 Singapore Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 182 Singapore Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 183 Singapore Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 184 Singapore Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 185 Singapore Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 186 Singapore Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 187 Singapore Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 188 Taiwan Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 189 Taiwan Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 190 Taiwan Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 191 Taiwan Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 192 Taiwan Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 193 Taiwan Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 194 Taiwan Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 195 Latin America Regulatory Affairs Market, by Country, 2018 - 2030 (USD Million)
  • Table 196 Latin America Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 197 Latin America Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 198 Latin America Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 199 Latin America Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 200 Latin America Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 201 Latin America Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 202 Latin America Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 203 Brazil Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 204 Brazil Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 205 Brazil Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 206 Brazil Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 207 Brazil Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 208 Brazil Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 209 Brazil Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 210 Argentina Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 211 Argentina Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 212 Argentina Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 213 Argentina Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 214 Argentina Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 215 Argentina Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 216 Argentina Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 217 Colombia Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 218 Colombia Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 219 Colombia Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 220 Colombia Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 221 Colombia Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 222 Colombia Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 223 Colombia Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 224 Chile Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 225 Chile Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 226 Chile Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 227 Chile Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 228 Chile Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 229 Chile Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 230 Chile Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 231 Middle East & Africa Regulatory Affairs Market, by Country, 2018 - 2030 (USD Million)
  • Table 232 Middle East & Africa Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 233 Middle East & Africa Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 234 Middle East & Africa Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 235 Middle East & Africa Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 236 Middle East & Africa Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 237 Middle East & Africa Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 238 Middle East & Africa Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 239 South Africa Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 240 South Africa Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 241 South Africa Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 242 South Africa Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 243 South Africa Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 244 South Africa Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 245 South Africa Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 246 Saudi Arabia Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 247 Saudi Arabia Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 248 Saudi Arabia Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 249 Saudi Arabia Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 250 Saudi Arabia Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 251 Saudi Arabia Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 252 Saudi Arabia Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 253 UAE Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 254 UAE Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 255 UAE Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 256 UAE Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 257 UAE Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 258 UAE Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 259 UAE Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 260 Egypt Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 261 Egypt Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 262 Egypt Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 263 Egypt Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 264 Egypt Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 265 Egypt Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 266 Egypt Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 267 Israel Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 268 Israel Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 269 Israel Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 270 Israel Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 271 Israel Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 272 Israel Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 273 Israel Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 274 Kuwait Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
  • Table 275 Kuwait Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
  • Table 276 Kuwait Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
  • Table 277 Kuwait Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
  • Table 278 Kuwait Regulatory Affairs Market, by Type, 2018 - 2030 (USD Million)
  • Table 279 Kuwait Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 280 Kuwait Regulatory Affairs Market, by End-Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Regulatory Affairs Market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot 1
  • Fig. 14 Segment snapshot 2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Regulatory Affairs Market: Services outlook key takeaways
  • Fig. 20 Regulatory Affairs Market: Services movement analysis
  • Fig. 21 Regulatory consulting market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Legal representation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Regulatory writing & publishing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Writing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Publishing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Product registration & clinical trial applications market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Other services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Regulatory Affairs Market: Category outlook key takeaways
  • Fig. 29 Regulatory Affairs Market: Category movement analysis
  • Fig. 30 Drugs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Innovator drugs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Preclinical innovator drugs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Clinical innovator drugs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Pre-Market Approval (PMA) innovator drugs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Generic drugs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Preclinical generic drugs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Clinical generic drugs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Pre-Market Approval (PMA) generic drugs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Biologics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Biotech market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Preclinical biotech market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Clinical biotech market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Pre-Market Approval (PMA) biotech market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 ATMP market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Preclinical ATMP market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Clinical ATMP market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Pre-Market Approval (PMA) ATMP market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Biosimilars market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Preclinical biosimilars market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Clinical biosimilars market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Pre-Market Approval (PMA) biosimilars market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Medical Devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Preclinical diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Clinical diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Pre-Market Approval (PMA) diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Preclinical therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Clinical therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Pre-Market Approval (PMA) therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Regulatory Affairs Market: Indication outlook key takeaways
  • Fig. 62 Regulatory Affairs Market: Indication movement analysis
  • Fig. 63 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Neurology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Cardiology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Immunology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Regulatory Affairs Market: Product stage outlook key takeaways
  • Fig. 69 Regulatory Affairs Market: Product stage movement analysis
  • Fig. 70 Preclinical market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Clinical studies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Pre-Market Approval (PMA) companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Immunology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Regulatory Affairs Market: Type outlook key takeaways
  • Fig. 75 Regulatory Affairs Market: Type movement analysis
  • Fig. 76 In-house market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Outsourced market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Regulatory Affairs Market: Company size outlook key takeaways
  • Fig. 79 Regulatory Affairs Market: Company size movement analysis
  • Fig. 80 Small market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Medium market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Large market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Regulatory Affairs Market: End-use outlook key takeaways
  • Fig. 84 Regulatory Affairs Market: End-use movement analysis
  • Fig. 85 Medical device companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Regional marketplace outlook, 2024 & 2030 (USD Million)
  • Fig. 89 Regional marketplace: Key takeaways
  • Fig. 90 North America Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 U.S. Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Canada Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Mexico Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Europe Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 UK regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 Germany Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 France Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 Italy Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Spain Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 Key country dynamics
  • Fig. 110 Denmark Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 111 Key country dynamics
  • Fig. 112 Norway Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 113 Key country dynamics
  • Fig. 114 Netherlands Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 115 Key country dynamics
  • Fig. 116 Switzerland Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 117 Key country dynamics
  • Fig. 118 Sweden Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 119 Asia Pacific Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 120 Key country dynamics
  • Fig. 121 Japan Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 122 Key country dynamics
  • Fig. 123 China Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 124 Key country dynamics
  • Fig. 125 India Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 126 Key country dynamics
  • Fig. 127 Australia Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 128 Key country dynamics
  • Fig. 129 South Korea Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 130 Key country dynamics
  • Fig. 131 Thailand Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 132 Key country dynamics
  • Fig. 133 Indonesia Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 134 Key country dynamics
  • Fig. 135 Taiwan Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 136 Key country dynamics
  • Fig. 137 Malaysia Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 138 Key country dynamics
  • Fig. 139 Singapore Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 140 Latin America Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 141 Key country dynamics
  • Fig. 142 Brazil Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 143 Key country dynamics
  • Fig. 144 Argentina Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 145 Key country dynamics
  • Fig. 146 Colombia regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 147 Key country dynamics
  • Fig. 148 Chile regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 149 Key country dynamics
  • Fig. 150 MEA Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 151 Key country dynamics
  • Fig. 152 South Africa Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 153 Key country dynamics
  • Fig. 154 Saudi Arabia Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 155 Key country dynamics
  • Fig. 156 UAE Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 157 Key country dynamics
  • Fig. 158 Egypt regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 159 Key country dynamics
  • Fig. 160 Israel regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 161 Key country dynamics
  • Fig. 162 Kuwait regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 163 Market participant categorization
  • Fig. 164 Regulatory affairs market share/assessment analysis, 2024
  • Fig. 165 Strategic framework